Johnson & Johnson Pull Vaginal Mesh Off The Market

June 6, 2012 - PRLog -- Johnson & Johnson has notified the court that they will be pulling four of their transvaginal mesh lines from the market. In addition, Johnson & Johnson will be making changes to the warning labels and instructions on those transvaginal mesh lines that will remain on the market. This is good news to many, as the surgeries have severe complications. These complications include: mesh erosion through the vaginal wall and internal organs, infection, extreme pain, urinary problems, prolapse recurrence, bladder- bowel-vessel perforation, scarring, pain during sexual intercourse, and other injuries that significantly decrease the quality of life.  

Woman suffering from any of the complications above should know, you are not alone.  In 2010, more than 75,000 women had transvagtinal mesh surgery to repair pelvic organ prolapse. Many woman have started their own local support groups for those dealing with transvaginal mesh surgeries and complications. These groups give woman the opportunity to share and speak with woman having similar experiences with this condition.  

“The group gives the woman a voice and helps them understand that they aren’t alone with this disease. Before I began this group, my only support was online. We welcome anyone to join!”April Lee, Local Support Group Leader

If you or a loved one has a transvaginal mesh used to correct pelvic organ prolapse and suffered from any of the complications above, the Defective Medical Device Attorneys at Hughes & Coleman are here to help. We believe in getting justice for all instances of medical negligence. We will work hard to get you the compensation you deserve.